Researchers at Columbia University Vagelos College of Physicians and Surgeons have uncovered how COVID-19 mRNA vaccines bolster the immune system by generating memory T and B cells, critical for long-term immunity...
During the COVID-19 pandemic, mRNA vaccines came to the rescue, developed in record time and saving lives worldwide. Harvard Medical School researchers at Boston Children’s Hospital have now developed two technologies...
From new vaccines to the first drugs of their kind for hard-to-treat disorders, 2023 has been a year full of medical breakthroughs. They offer opportunities for people to protect themselves from diseases, slow down the...
A study has revealed new details about a key population of immune system cells that were critical to successful vaccination against the pandemic virus, SARS-CoV-2. Led by researchers at NYU Grossman School of Medicine...
Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine. This is shown by a study from the University of Gothenburg on patients having undergone a bone...
For the first time in the world a team of researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine that is 100% effective against a type of bacteria that...
An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent...
China has not been using the kind of COVID-19 vaccine that has proven to offer the best protection against the virus. The country is working through its biggest coronavirus outbreak yet without a tool it could have...
The European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19 task force (ETF) have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines (Pfizer’s Comirnaty and...
First steps towards protection from the many and variable viral strains Volunteers in the US recently received the first experimental doses of a new type of HIV vaccine. Using Moderna’s mRNA platform, the vaccine has...